Zaire Ebola vaccine candidates

South Korea’s top automaker Hyundai Motor Co. has launched a global talent recruitment program, beginning April 1 via its official hiring webs...

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

Macquarie Asset Management has embarked on a process to sell off its 100% stake in South Korea’s third-largest industrial gas producer DIG Air...

South Korea's SK Bioscience Co. said on Friday it signed an expanded agreement with Sanofi to co-develop next-generation pneumococcal conjugate vacc...

Lotte Card Co. is expected to be up for grabs in the first half of next year amid a second sale attempt by its largest shareholder MBK Partners, a N...

South Korea’s Hanmi Pharmaceutical Co. announced on Thursday the launch of its anti-obesity drug candidate efpeglenatide has been rescheduled ...

Korea Electric Power Corp. (KEPCO), the South Korean state-run utility company, was shortlisted as a final candidate for renewable energy projects i...

SK Bioscience Co., a bio and pharmaceutical affiliate of South Korea's SK Group, said on Wednesday that The Indonesian Food and Drug Authority BPOM ...

To Hopae Inc., a digital identity solution-developing startup native to South Korea, its home market is small. After successfully accommodating more...

SK Bioscience Co., a drug-making arm of South Korea's No. 2 conglomerate SK Group, has sold a stake in Nasdaq-listed vaccine developer Novavax Inc. ...

South Korean sovereign wealth fund Korea Investment Corporation (KIC) has shortlisted three candidates as the next chief executive officer, who will...

South Korea’s vaccine developer SK Bioscience Co. will acquire a controlling stake in the world’s top 10 vaccine firm IDT Biologika GmbH...

South Korea's EuBiologics Co. announced on Friday that the vaccine bulk production facility at its Chuncheon Plant No. 2 for the oral cholera vacc...

South Korea's KT Corp. announced on Wednesday that it signed a business agreement with global mobile communications equipment manufacturer Nokia Cor...

South Korea's low-cost carrier Air Premia Inc. has teamed up with North Asia-focused private equity firm MBK Partners to win Asiana Airlines Inc.'s ...

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, is slated to vote in favor of the KT&G Corp. b...

South Korea's SK Bioscience Co. announced on Thursday that it has shipped about 440,000 doses (for single-dose administration) of its cell-cultured ...

Global leading proxy advisor Institutional Shareholder Services Inc. (ISS) has recommended that stakeholders of South Korean tobacco maker KT&G ...

South Korean brokerage house NH Investment & Securities Co. has shortlisted three candidates for its next chief executive as the current CEO Jeo...

South Korea’s KT&G Corp., the world’s leading tobacco maker, appointed its Chief Operating Officer Bang Kyung-man as the final candi...

Samsung Biologics Co. has agreed with South Korean biotech company LegoChem Biosciences Inc. to provide contract development organization (CDO) serv...

South Korea’s LG Chem Ltd. announced on Wednesday that its US-based subsidiary Aveo Pharmaceuticals will start Phase 3 clinical trials for its...

Kobiolabs Co., a South Korean microbiome-based new drug development company, announced on Wednesday that it has a patent for Roseburia intestinalis ...

LG Chem Ltd. has agreed to license out a rare genetic obesity drug candidate in phase 2 clinical trials to Rhythm Pharmaceuticals Inc., a US biotech...

POSCO Holdings Inc.'s Chairman Choi Jeong-woo is not among the company’s next CEO candidates, suggesting Choi will leave the company after ser...

Sixth-generation (6G) communication frequency bands proposed by South Korea have been adopted as global standard candidates by the industry's freq...

South Korea's SK Bioscience Co. announced on Tuesday that it started to deliver the Novavax COVID-19 vaccine against XBB.1.5 variant.According to No...

South Korea's SK Bioscience Co. announced on Monday that it submitted the Investigational New Drug (IND) application for the Phase 3 clinical trial ...

South Korea's ISU Abxis Co. announced on Friday that its Alzheimer's treatment candidate ISU203 has received a substance patent registration decisio...

South Korea’s health ministry will allocate 261.6 billion won ($200.2 million) for two funds over the next four years to boost private sector ...